Organ-on-chip applications in drug discovery: an end user perspective
Naomi Clapp, Augustin Amour, Wendy C. Rowan, Pelin L. Candarlioglu
GlaxoSmithKline (United Kingdom) GlaxoSmithKline (Ireland)
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Organ-on-chip (OoC) systems are in vitro microfluidic models that mimic the microstructures, functions and physiochemical environments of whole living organs more accurately than two-dimensional models. While still in their infancy, OoCs are expected to bring ground-breaking benefits to a myriad of applications, enabling more human-relevant candidate drug efficacy and toxicity studies, and providing greater insights into mechanisms of human disease. Here, we explore a selection of applications of OoC systems. The future directions and scope of implementing OoCs across the drug discovery process are also discussed.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
工程3D Printing in Biomedical Research
Innovative Microfluidic and Catalytic Techniques Innovation · Neuroscience and Neural Engineering
参考文献 81
此处列出前 3 条
引用本文 40
按被引量排序,此处列出前 3 条